Full Text Journal Articles by
Author Samuel M Galvagno

Advertisement

Find full text journal articles






COVID-19 outcomes of venovenous extracorporeal membrane oxygenation for acute respiratory failure vs historical cohort of non-COVID-19 viral infections.

Sagar B Dave, Ronald Rabinowitz, Aakash Shah, Ali Tabatabai, Samuel M Galvagno, Michael A Mazzeffi, Raymond Rector, David J Kaczorowski, Thomas M Scalea, Jay Menaker,

<h4>Introduction</h4>Veno-venous extracorporeal membrane oxygenation (VV ECMO) has become a support modality for patients with acute respiratory failure refractory to standard therapies. VV ECMO has been increasingly used during the current COVID-19 pandemic for patients with refractory respiratory failure. The object of this study was to evaluate the outcomes of VV ... Read more >>

Perfusion (Perfusion)
[2022, :2676591221105603]

Cited: 0 times

View full text PDF listing >>



Body mass index does not impact survival in COVID-19 patients requiring veno-venous extracorporeal membrane oxygenation.

Elizabeth K Powell, Daniel J Haase, Allison Lankford, Kimberly Boswell, Emily Esposito, Joseph Hamera, Siamak Dahi, Eric Krause, Gregory Bittle, Kristopher B Deatrick, Bree Ann C Young, Samuel M Galvagno, Ali Tabatabai,

<h4>Introduction</h4>With the increased demand for veno-venous extracorporeal membrane oxygenation (VV ECMO) during the COVID-19 pandemic, guidelines for patient candidacy have often limited this modality for patients with a body mass index (BMI) less than 40 kg/m<sup>2</sup>. We hypothesize that COVID-19 VV ECMO patients with at least class III obesity (BMI ≥ ... Read more >>

Perfusion (Perfusion)
[2022, :2676591221097642]

Cited: 0 times

View full text PDF listing >>



Advertisement


Disclaimer

0.5055 s